Flagship Harbor Advisors’s VanEck Biotech ETF BBH Stock Holding History
Bought
Maintained
Sold
Other funds holding BBH
MIM
CCA
BFG
Flagship Harbor Advisors's BBH Position: Q1 2026 in Review
Flagship Harbor Advisors increased its VanEck Biotech ETF (BBH) stake by 840% in Q1 2026, buying an estimated $404K and bringing the position to 2,349 shares worth $442K. The position accounts for 0.02% of the portfolio, ranked #504.
Flagship Harbor Advisors first reported a position in BBH in Q2 2018 and has held it in 18 quarters since. 112 funds tracked by Wall St. Rank hold BBH as of Q1 2026.
- Flagship Harbor Advisors held 2,349 shares of VanEck Biotech ETF worth $442K as of Q1 2026.
- Flagship Harbor Advisors bought 2,099 VanEck Biotech ETF shares in Q1 2026, an estimated $404K.
- VanEck Biotech ETF made up 0.02% of Flagship Harbor Advisors's portfolio in Q1 2026, its #504 holding.
- Flagship Harbor Advisors first reported a position in VanEck Biotech ETF in Q2 2018 and has held it in 18 quarters since.
- 112 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2026.
Based on Flagship Harbor Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.